SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-070308
Filing Date
2015-09-11
Accepted
2015-09-11 15:20:05
Documents
1
Period of Report
2015-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8669
  Complete submission text file 0001209191-15-070308.txt   10207
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Issuer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PO BOX 58154 SALT LAKE CITY UT 84158
Business Address
BORST STEVEN JOHN (Reporting) CIK: 0001532620 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52062 | Film No.: 151103304